Sign up to save your podcasts
Or
Share Eli Lilly and Company (LLY), 2025 Q1 earnings digest
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Eli Lilly and Company (LLY), 2025 Q1 earnings digest
$LLY announced its Q1 2025 earnings results, with revenue reaching $12.73B, up 45% Y/Y, while EPS of $3.34 missed estimates by $0.12. Risks include competition and pricing pressures, particularly for Zepbound following CVS’ formulary changes.
View all episodes
By ValueVerge$LLY announced its Q1 2025 earnings results, with revenue reaching $12.73B, up 45% Y/Y, while EPS of $3.34 missed estimates by $0.12. Risks include competition and pricing pressures, particularly for Zepbound following CVS’ formulary changes.